- Implementation Support Agency (ISA): World Bank
- Total project financing: $63.75 million
- Funding from GCFF: $12.5 million
- GCFF Financing Approval Date: 06/05/2021
- Project Closing Date: 01/31/2024
- % Disbursed: 80.7%
- Status: Under implementation
About the project
The purpose of the proposed AF is to provide financing to help the Government of Jordan (GOJ) purchase and deploy COVID-19 vaccines that meet the World Bank’s vaccine approval criteria (VAC), strengthen relevant health systems that are necessary for successful vaccine deployment, and prepare for future epidemics. The need for additional resources to expand the COVID-19 response was formally conveyed by the GOJ on December 27, 2020. The proposed AF form part of an expanded health response to the COVID-19 pandemic, which is being supported by development partners under the coordination of the GOJ. Additional World Bank financing provide essential resources to enable the expansion of a sustained and comprehensive pandemic response that will appropriately include vaccination in Jordan. Critically, the AF seeks to enable the acquisition of vaccines from a range of sources to support Jordan’s objective to have a portfolio of options to access vaccines under the right conditions (of value-for-money, regulatory approvals, and delivery time among other key features). The AF is aligned with the World Bank Group (WBG) Country Partnership Framework (CPF) for Jordan for FY17– FY22 (Report 102746-JO).
Project Development Objective (PDO)
To prevent, detect, and respond to the threat posed by COVID-19 and strengthen the national health system for public health preparedness. The Parent Project includes three components: Component 1: Emergency COVID-19 Response ($19.45 million); Component 2: Implementation Management and Monitoring and Evaluation ($0.5 million); and Component 3: Contingent Emergency Response Component (CERC) ($0 million).